finanzen.net

QIAGEN Aktie WKN: A2DKCH     / ISIN: NL0012169213    

34,36EUR
+0,16EUR
+0,47%
14:06:19
37,31USD
+0,14USD
+0,38%
20.02.2020
KAUFEN
VERKAUFEN
mehr Daten anzeigen

QIAGEN Aktien News

06:00 Uhr
BB BIOTECH AG : BB Biotech AG publishes its 2019 annual report (Investegate)
19.02.20
FDA grants priority review to Roche’s Tecentriq monotherapy as first-line treatment of certain people with advanced non-small cell lung cancer (Roche Holding AG)
19.02.20
F. Hoffmann-La Roche Ltd : FDA grants priority review to Roche’s Tecentriq monotherapy as first-line treatment of certain people with advanced non-small cell lung cancer (Investegate)
14.02.20
Evotec SE : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
14.02.20
China National Medical Products Administration grants approval of Roche’s Tecentriq in combination with chemotherapy as first-line treatment of people with extensive-stage small cell lung cancer (Roche Holding AG)
10.02.20
Roche Reports Disappointing Data on Alzheimer's Disease Drug (Zacks)
10.02.20
Roche and Eli Lilly drugs fail ‘inherited’ Alzheimer’s trial (Financial Times)
10.02.20
Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease (Reuters)
10.02.20
The Zacks Analyst Blog Highlights: Alphabet, Roche, Amgen, General Electric and Sony (Zacks)
10.02.20
UPDATE 2-Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease (Reuters)
10.02.20
Competition and Mkts : Merger Update: Roche Holdings/Spark Therapeutics (Investegate)
10.02.20
UPDATE 1-Roche drug fails in early-onset Alzheimer's disease study (Reuters)
10.02.20
Roche drug fails in early-onset Alzheimer's disease study (Reuters)
10.02.20
Roche provides topline results from investigator-led Phase II/III trial with gantenerumab in rare inherited form of Alzheimer’s disease (Roche Holding AG)
10.02.20
F. Hoffmann-La Roche Ltd : Roche provides topline results from investigator-led Phase II/III trial with gantenerumab in rare inherited form of Alzheimer’s disease (Investegate)
08.02.20
Is Amgen a Stock to Buy? (MotleyFool)
07.02.20
Roche Presents Spinal Muscular Atrophy Drug Data (MotleyFool)
07.02.20
Evotec SE : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
06.02.20
Amgen Stock Relative Strength Climbs Ahead Of Key Drug Data (Investors Business Daily)
06.02.20
Roche’s risdiplam showed significant improvement in motor function in people aged 2-25 with type 2 or 3 spinal muscular atrophy (Roche Holding AG)
06.02.20
F. Hoffmann-La Roche Ltd : Roche’s risdiplam showed significant improvement in motor function in people aged 2-25 with type 2 or 3 spinal muscular atrophy (Investegate)
06.02.20
Why Amgen Stock Dropped 10.4% in January (MotleyFool)
05.02.20
Infographic: How to find effective endometriosis treatments (EN, Evotec)
02.02.20
Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors? (MotleyFool)
31.01.20
Exxon Mobil, Amgen fall; Amazon, IBM rise (Seattle Times)
31.01.20
Stock Market News: Amazon's Amazing; Amgen Falls Short (MotleyFool)
31.01.20
How A Rumored Amgen Takeover Sent This Biotech Stock Flying (Investors Business Daily)
31.01.20
KB Home, National Beverage, Amazon, Visa and Amgen highlighted as Zacks Bull and Bear of the Day (Zacks)
31.01.20
MorphoSys AG : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
31.01.20
Amgen (AMGN) Stock Down Despite Q4 Earnings & Revenue Beat (Zacks)
31.01.20
Evotec SE : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
31.01.20
Amgen Inc (AMGN) Q4 2019 Earnings Call Transcript (MotleyFool)
31.01.20
Amgen Revenue Slipped 1% in the Fourth Quarter (MotleyFool)
31.01.20
Amgen 2020 outlook falls short of Street estimates; shares slump (Reuters)
31.01.20
Amgen 2020 outlook falls short of Street estimates; shares slump (Reuters)
30.01.20
Amgen 2020 outlook falls short of Street estimates, shares down 3% (Reuters)
30.01.20
Amgen (AMGN) Q4 Earnings and Revenues Surpass Estimates (Zacks)
30.01.20
Amgen 2020 outlook falls short of Street estimates, shares down 3% (Reuters)
30.01.20
Amgen quarterly profit beats estimates, 2020 outlook falls short (Reuters)
30.01.20
Amgen quarterly profit beats estimates, 2020 outlook falls short (Reuters)
Seite: 123456789...25

QIAGEN News

QIAGEN News: auf dieser Seite finden Sie alle QIAGEN News und Nachrichten zur QIAGEN Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch QIAGEN News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um QIAGEN News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
NEL ASAA0B733
TeslaA1CX3T
Ballard Power Inc.A0RENB
PowerCell Sweden ABA14TK6
Wirecard AG747206
Plug Power Inc.A1JA81
Deutsche Bank AG514000
Allianz840400
Daimler AG710000
Varta AGA0TGJ5
Deutsche Telekom AG555750
ITM Power plcA0B57L
Microsoft Corp.870747
Apple Inc.865985
SteinhoffA14XB9